World ADC 2022 presentation titled, “A New Molecular Class to target Tumor Immunity by both disrupting the tumor and enabling the immune system” presented by  Trevor Hallam, Ph.D., President of Scientific and Chief Scientific Officer.

World ADC 2022 presentation titled, “Targeting FolRα in Gynecologic Cancers & other Solid Tumours with the Novel Antibody-Drug Conjugate, STRO-002” presented by Arturo Molina, MD, MS, Chief Medical Officer.